The information on (or referenced by) the EFFORTS’ website and discussion lists is not intended or
implied to be a substitute for the professional medical advice of your own healthcare providers.
We thank those who have shopped at Amazon and donated to EFFORTS through the Smile program. On February 20th 2023,
Amazon discontinued the program.
If you would like to donate to EFFORTS, click the Paypal Donate button or mail a check to PO Box 20241
Kansas City, MO 64195–0241.
As a patient advocacy group, we rely on your contributions/donations to maintain the mail list
group, this website, and help board members attend conferences and to increase our participation in research.
COPD Resources and News for Living and Advocacy
WELCOME TO EFFORTS!
Emphysema Foundation For Our
Right To Survive
has collected COPD news and resources including videos, books, advocacy tips, trials, and
Living with COPD, while a change in lifestyle, is not a death sentence.
Have you been recently/newly diagnosed with a MAC lung infection? MAC is the most common form of
nontuberculous mycobacteria (NTM). NTM are bacteria commonly found in the environment. MAC can
get inside your lungs when you breathe them in and can affect certain people more than others. Most
people who come in contact with MAC do not develop an infection. However, some individuals are at a
greater risk of developing an infection called MAC lung disease. MAC lung disease is a serious
If untreated, it can cause damage to the lungs.
A new study is looking for individuals with newly diagnosed MAC lung disease who may be interested in
participating in a clinical study that is evaluating a drug for potential treatment of MAC lung
infections and for the
potential to improve symptoms of MAC lung infection including decreased respiratory discomfort and
Your participation in the study could potentially contribute to advancements in MAC lung disease
LEEP Losartan Effects on Emphysema Progression LEEP is a randomized clinical trial evaluating the effect
of Losartan in helping people
with Chronic Obstructive Pulmonary Disease (COPD) with emphysema – a disease of the lungs. We
are looking for adults 40
years of age or older, current or former smokers, with COPD to join our study. The study is
conducted in different states
across the country.
Insight COPD Intervention Study In Overweight Patients with COPD We are trying to find out if a program
proven to help people lose a modest
amount of weight and increase their physical activity will improve COPD symptoms for those with a high BMI.
To be in the study, you will
need to have COPD, high BMI, history of smoking, shortness of breath, and be 40 years or
RETHINC REdefining Therapy IN early COPD The purpose of the RETHINC study is to determine whether
symptomatic current and former smokers
with normal lung function will benefit from the use of bronchodilator therapy currently used to treat patients
who have Chronic Obstructive
Pulmonary Disease (COPD).
Pulmonary Fibrosis Click
link to find many clinical trials avilable offered for Idiopathic Pulmonary Fibrosis, Cystic Fibrosis,
Pulmonary Fibrosis by Clinicaltrials.gov
COPD Foundation Research Click Research on the main